全國服務咨詢熱線：
18860915427
18860915427
產品分類
Product Category詳細介紹
| 品牌 | absin | CAS | 761437-28-9 |
|---|---|---|---|
| 分子式 | C23H25ClN6O3 | 純度 | ＞98% |
| 分子量 | 468.94 | 貨號 | abs810514 |
| 規格 | 5mg | 供貨周期 | 現貨 |
| 主要用途 | is a potent FAK inhibitor with IC50 of 5 | 應用領域 | 化工,生物產業,農林牧漁,制藥/生物制藥,綜合 |
TAE-226 761437-28-9
| 產品描述 | |
| 描述 | TAE226 (NVP-TAE226) is a potent FAK inhibitor with IC50 of 5.5 nM and modestly potent to Pyk2, ~10- to 100-fold less potent against InsR, IGF-1R, ALK, and c-Met. |
| 純度 | >98% |
| 儲存/保存方法 | Store at -20℃ for one year（Powder）；Store at 2-4℃ for two weeks；Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 別名 | TAE226, TAE-226,TAE 226,NVPTAE226 |
| 外觀 | Powder |
| 可溶性/溶解性 | DMSO 94 mg/mL (200.45 mM) |
| 生物活性 | |
| 靶點 | PYK2 ,FAK ,Insulin Receptor ,IGF-1R ,c-Met |
| In vitro(體外研究) | NVP-TAE226 ( NVP-TAE226 (5 μM) inhibits phosphorylation of FAK in the human neuroblastoma cell line SK-N-AS. NVP-TAE226 ( NVP-TAE226 (0.1 μM-10 μM) inhibits tube formation of HMEC1 cells. |
| In vivo(體內研究) | NVP-TAE226 (75 mg/kg) significantly increases the survival rate of mice bearing intracranial glioma xenografts. NVP-TAE226 (100 mg/kg, oral) exerts significant decrease in microvessel density in a human colon cancer model in SCID mice. NVP-TAE226 (100 mg/kg, oral) efficiently inhibits MIA PaCa-2 human pancreatic tumor growth without body weight loss in vivo model. NVP-TAE226 inhibits 4T1 murine breast tumor growth and metastasis to the lung in a dose-dependent manner in vivo model, associated with inhibition of FAK autophosphorylation at Y397 and Akt phosphorylation at Serine473. |
| 研究領域 | |
| 研究領域 | CancerCancer MetabolismResponse to hypoxia MetabolismPathways and ProcessesMetabolism processesHypoxia Signal TransductionProtein PhosphorylationTyrosine KinasesFAK / PYK Signal TransductionProtein PhosphorylationTyrosine KinasesOther Drug DiscoverySmall Molecule DrugLead Compound Discovery |
產品咨詢
電話
微信掃一掃
地址：上海市浦東新區新浩路58號申江科創園18棟
郵箱：fengmj@univ-bio.com
傳真：